Background. To overcome obstacles within the Slovenian organised cervical cancer
screening programme, a randomised pilot study of human papillomavirus (HPV) self …

Background This study aimed to assess the acceptability and attitudes of women towards
human papillomavirus (HPV) self-sampling and compare the effectiveness of two delivery …

An increasing body of evidence supports the validity of self-sampling as an alternative to
clinician collection for primary Human Papillomavirus (HPV) screening. Self-sampling …

Studies in Western countries with organized screening programs (12–14) reported that
providing self-sampling kits to women who did not participate, particularly when in addition …

Objective Cervical cancer screening coverage remains insufficient in most countries. Testing
self-collected samples for high-risk human papillomavirus (HR-HPV) could be an alternative …

Background Cervical cancer is almost entirely preventable with appropriate and timely
screening. In Ontario, Canada, South Asian, Middle Eastern and North African women have …

Cervical cancer is the third most common gynecological cancer worldwide. Its origin is
linked to intraepithelial lesions caused by high-risk Human Papillomavirus (HPV) types …

Objective To investigate whether self‐sampling is as reliable as professional sampling for
HPV testing and genotype detection among postmenopausal women. Methods In the …

In 2017 the cervical cancer screening program in The Netherlands will be revised. Cervical
smears will primarily be tested for the presence of high-risk human papillomavirus (hrHPV) …

Background: Cervical cancer is the fourth most common cancer in the world. A raised
incidence and mortality parallel a low participation rate in screening, namely screening in …